Inria Sophia Antipolis Méditerranée is leading SimCardioTest, a new EU project funded with 8 million Euros that will provide insight into designing new predictive tools in cardiac pathologies. Among the ten partners, the rising startup InSilicoTrials. The search for new drugs and devices is
More
AFPE is excited to announce the recipients of our Pre-Doctoral Fellowships and
Bio and generic demand driving increased internationalisation and renewed optimism amongst industry
New program combines human hello to digital embrace for long-term medication support Boston, MA – Medisafe, a leading digital drug companion company, is
More
Davis, CA: Botanical Solution Inc. (BSI), innovator of sustainable, highly consistent and cost effective Advanced Botanical Materials, has successfully secured $3.3 million
More
Manufacturers seeking CDMOs that can quickly develop complex formulations offering both body and mind benefits SIRIO Europe (Ayanda) – the European nutraceutical
More
Chippenham, UK: Vectura Group plc, an industry leading inhalation CDMO, today announces that it has signed a global out licence
MoreMedisafe, a leading digital therapeutics company specializing in digital companions, has been selected by UCB to develop branded digital drug
More
New clinical research conducted by the University of Sherbrooke, Canada, published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, has
More
NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) a global leader in the development of highly effective antiviral therapies based on a
More
Publishers responsible for tens of thousands of peer-reviewed journals and books have signed an agreement to take a proactive stance
More
Encouragingly, the industry might be 30% along its sustainability journey, but greater interoperability needed from materials to devices for the
More
ABX464 is the only drug candidate with a potential triple action for COVID-19 treatment: antiviral, anti-inflammatory and tissue repair ABX464,
More
